Sugi Predict

Sugi Predict / Compounds / SCHEMBL6809764

SCHEMBL6809764

SCHEMBL6809764

CC(OP(O)O)(c1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ MAPK1 P28482 1/20 0.44
▸ ESR1 P03372 3/20 0.40
▸ ESR2 Q92731 3/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ KCNN4 O15554 4/20 0.39
▸ MAPT P10636 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ CYP2C19 P33261 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ TAAR1 Q96RJ0 1/20 0.37
▸ HDAC3 O15379 1/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC7 Q8WUI4 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ HDAC10 Q969S8 1/20 0.36
▸ HDAC11 Q96DB2 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18544240 0.82 ALDH1A1 (0.58) ALDH1A1ALOX15MAPK1ESR1ESR2
SCHEMBL6809763 0.81 MAPK1 (0.48) ALDH1A1ALOX15MAPK1ESR1ESR2
SCHEMBL4462032 0.78 ALDH1A1 (0.43) ALDH1A1ALOX15MAPK1ESR1ESR2
SCHEMBL11127929 0.77 MAPK1 (0.44) ALDH1A1ALOX15MAPK1ESR1ESR2
SCHEMBL4448590 0.77 ALDH1A1 (0.42) ALDH1A1ALOX15MAPK1ESR1ESR2
SCHEMBL4462382 0.77 ALDH1A1 (0.42) ALDH1A1ALOX15MAPK1ESR1ESR2
SCHEMBL3969286 0.76 KIF11 (0.40) ALDH1A1ALOX15MAPK1ESR1ESR2
SCHEMBL11147173 0.76 ALDH1A1 (0.39) ALDH1A1ALOX15MAPK1ESR1ESR2
SCHEMBL18544226 0.74 CYP2D6 (0.41) ALDH1A1ALOX15MAPK1ESR1ESR2
SCHEMBL9494144 0.74 CYP2D6 (0.41) ALDH1A1ALOX15MAPK1ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112745497-A Semi-aromatic polyamide resin and preparation method and application thereof 南京开创新材料科技有限公司 2021-05-04 — — CN claimed
CN-112679728-A Semi-aromatic polyamide resin and preparation method thereof 南京开创新材料科技有限公司 2021-04-20 — — CN claimed
CN-119406454-A Phosphorus-containing porous organic polymer supported nickel catalyst and preparation method thereof 兰州大学 2025-02-11 — — CN disclosed
US-12043721-B2 Antiviral/antimicrobial polymer compositions, fibers, and products ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) 2024-07-23 — — US disclosed
US-20240002313-A1 [11C]-LABELED ACYCLIC RETINOID, CENTRAL NERVOUS SYSTEM ACTIVATOR, AND PRODUCTION METHODS FOR SAME NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY (JP) 2024-01-04 — — US disclosed
CN-117098749-A [11C] Labeled acyclic retinoids, central nervous system activators and methods for their manufacture 国立研究开发法人国立长寿医疗研究中心 2023-11-21 — — CN disclosed
EP-4249058-A1 [11C]-LABELLED ACYCLIC RETINOID, CENTRAL NERVOUS SYSTEM ACTIVATOR, AND PRODUCTION METHODS FOR SAME National Center for Geriatrics and Gerontology (JP) 2023-09-27 — — EP disclosed
US-20230234917-A1 ASPARAGINE DERIVATIVES AND METHODS OF USING SAME SENDA BIOSCIENCES INC (US) 2023-07-27 — — US disclosed
WO-2021252640-A1 ASPARAGINE DERIVATIVES AND METHODS OF USING SAME SENDA BIOSCIENCES, INC. (US) 2021-12-16 — — WO disclosed
CN-106661065-B Crystal of cyclic phosphonic acid sodium salt and method for producing same 大塚化学株式会社 2021-09-24 — — CN disclosed
US-20210246256-A1 POLYURETHANE FOAM OR POLYETHER POLYOL STABILIZED WITH A BENZOFURANONE-PHOSPHITE DERIVATIVE BASF SE (DE) 2021-08-12 — — US disclosed
EP-0262202-B1 METHOD FOR PREPARING PENICILLANIC ACID DERIVATIVES LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 1992-07-01 — — EP disclosed
EP-0197311-B1 PROCESS FOR POLYMERIZING ETHYLENE MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1991-12-18 — — EP disclosed
US-4762898-A Process for polymerizing ethylene MITSUBISHI PETROCHEMICAL COMPANY LIMITED (JP) 1988-08-09 — — US disclosed
EP-0267794-A2 Process for preparing polyolefins Nippon Petrochemicals Co., Ltd. (JP) 1988-05-18 — — EP disclosed
US-4525555-A TITANIUM COMPOUND SUPPORTED ON SOLID REACTION PRODUCT OF MAGNESIUM HALIDE, SILOXANES, ORGANIC COMPOUNDS NIPPON OIL COMPANY, LIMITED (JP) 1985-06-25 — — US disclosed
US-4135045-A PROCESS FOR POLYMERIZATION OF OLEFINS AND CATALYST COMPOSITION THEREFOR MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1979-01-16 — — US disclosed
US-4067903-A Manufacture of arylamines BASF AKTIENGESELLSCHAFT (DT) 1978-01-10 — — US disclosed
US-4048415-A TITANIUM-ALUMINUM COORDINATION CATALYSTS MITSUI PETROCHEMICAL INDUSTRIES LTD. (JA) 1977-09-13 — — US disclosed
US-4036809-A Halogen-containing diphosphonates ETHYL CORPORATION (US) 1977-07-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240002313-A1 [11C]-LABELED ACYCLIC RETINOID, CENTRAL NERVOUS SYSTEM ACTIVATOR, AND PRODUCTION METHODS FOR SAME NR2E3, FABP7, RARB ALDH1A1 307/4885ALOX15 2467/4885MAPK1 1863/4885
US-20230234917-A1 ASPARAGINE DERIVATIVES AND METHODS OF USING SAME ASNS, SI, NARS1 ALDH1A1 1286/4885ALOX15 2305/4885MAPK1 4235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.